Sign in

CIK 0001728117

  • Non-accelerated filer
  • Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475461709
Phone
+1 858-684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-24 Peterson Caryn Chief Development Officer Grant or award · Stock Option (Right to Buy) +5,800,051 5,800,051
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −506,250 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −440,000 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −375,000 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −125,000 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −157,500 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −157,500 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −126,667 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −21,167 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −18,834 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −22,784 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −9,167 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Returned to the company · Stock Option (Right to Buy) −32,334 0
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +506,250 506,250
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +440,000 440,000
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +375,000 375,000
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +125,000 125,000
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +157,500 157,500
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +157,500 157,500
2026-03-19 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +126,667 126,667

Page 1 of 3 · 53 trades